Sunitinib is a multi-targeted receptor tyrosine kinase (RTK) inhibitor primarily used as an oral anti-cancer medication for the treatment of renal cell carcinoma, imatinib-resistant gastrointestinal stromal… Read more












![Chemical structure of 5,5'-Difluoro-3,3'-dihydroxy-[3,3'-biindoline]-2,2'-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1609011-41-7-55-Difluoro-33-dihydroxy-33-biindoline-22-dione.png&w=3840&q=75)
![Chemical structure of 5,5'-Difluoro-3-hydroxy-[3,3'-biindoline]-2,2'-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F55-Difluoro-3-hydroxy-33-biindoline-22-dione.png&w=3840&q=75)




![Chemical structure of Bis((1H-benzo[d][1,2,3]triazol-1-yl)oxy)methane](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F83615-76-3-Bis1H-benzod123triazol-1-yloxymethane.png&w=3840&q=75)







![Chemical structure of N-[2-(Diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F356068-86-5-N-2-Diethylaminoethyl-5-formyl-24-dimethyl-1H-pyrrole-3-carboxamide.png&w=3840&q=75)























Sunitinib is a multi-targeted receptor tyrosine kinase (RTK) inhibitor primarily used as an oral anti-cancer medication for the treatment of renal cell carcinoma, imatinib-resistant gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors. This catalogue provides a comprehensive selection of Sunitinib reference standards, including synthetic intermediates, process-related impurities, degradation products, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for critical analytical workflows such as impurity profiling, forced degradation studies, and method validation to ensure regulatory compliance and product consistency. By incorporating these characterized standards into quality control processes, researchers can accurately monitor the purity of the active pharmaceutical ingredient and identify potential nitrosamine contaminants or other structural analogs that may arise during synthesis and formulation. These essential compounds support precise quantification and reliable stability testing within the development and manufacturing of this vital oncology therapy.